Epigenetics Market Analysis

Therapy Type (HDAC, DNMT)

HDAC segment is likely to hold more than 67% epigenetics market share by 2037. It is expected to around USD 3 billion by 2037, growing at a CAGR of 8%. The growth in this sector is due to HDAC inhibitors showing great results in fighting various cancers, including blood cancers and tumors. The US FDA has given the green light to HDAC inhibitors for treating different cancers, like cutaneous T cell lymphoma (CTCL). Moreover, new methods have made HDAC inhibitors more efficient in tackling specific diseases, enhancing their performance.

Applications (Oncology, Non-Oncology)

By the end of 2037, oncology segment is projected to capture around 70% epigenetics market share. The segment growth is fueled by a rising need for drugs based on gene control in both spotting and treating cancer. This market expansion is shaped by the push towards more precise medicine and therapies aimed directly at cancer traits. This shift towards precision medicine and focused treatments spurs the necessity for gene control analysis, thus boosting the growth of the oncology application section. Meanwhile, the non-oncology application sub-segment is also on an upward trend. It expected to grow at a rate of 15.30% from 2024 to 2030. This growth reflects a broad interest in refining treatment strategies across various medical fields, emphasizing the crucial role of gene control studies in modern healthcare advancements.

Diagnostic Technologies (DNA Methylation, CHIP, Others)  

In epigenetics market, DNA methylation segment is estimated to capture over 46.8% revenue share by 2037. The segment growth is linked to the growing use of DNA methylation in drug research and production, along with the drop in genome sequencing costs, boosts market expansion. In 2024, the DNA Methylation Sequencing market stood at USD 1.21 billion and is projected to hit USD 3.6 billion by 2032, marking a CAGR of 17.3% from 2024 to 2032. Currently, the market offers several in vitro diagnostic tests that utilize DNA methylation analysis of specific genes. DNA methylation plays a crucial role in gene control as a fundamental epigenetic change. Progress in DNA methylation detection methods is making diagnostic tests more precise and sensitive, thereby improving their ability to pinpoint epigenetic changes tied to illnesses.

Our in-depth analysis of the market includes the following segments: